Evidence map›Paper›PMID 33630019›Full record

ArticleThe Journal of experimental medicine2021

NK/ILC1 cells mediate neuroinflammation and brain pathology following congenital CMV infection.

Daria Kveštak, Vanda Juranić Lisnić, Berislav Lisnić, Jelena Tomac, Mijo Golemac, Ilija Brizić, Daniela Indenbirken, Maja Cokarić Brdovčak, Giovanni Bernardini, Fran Krstanović and 5 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of experimental medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 57 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Acute peritonitis-induced adipose CD127Nature communications · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Immune surveillance of cytomegalovirus in tissues.Cellular & molecular immunology · 2024
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 4 countries.

Daria KveštakDepartment of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Vanda Juranić LisnićDepartment of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Berislav LisnićDepartment of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Jelena TomacDepartment of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Mijo GolemacDepartment of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Ilija BrizićCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Daniela IndenbirkenHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Maja Cokarić BrdovčakCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Giovanni BernardiniDepartment of Molecular Medicine, Faculty of Pharmacy and Medicine, University of Rome "Sapienza", Rome, Italy.
Fran KrstanovićCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Carmen RožmanićCenter for Proteomics, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
Adam GrundhoffHeinrich Pette Institute, Leibniz Institute for Experimental Virology, Hamburg, Germany.
Astrid KrmpotićDepartment of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
William J BrittDepartment of Microbiology, University of Alabama at Birmingham, Birmingham, AL.
Stipan JonjićDepartment of Histology and Embryology, Faculty of Medicine, University of Rijeka, Rijeka, Croatia.
University of Rijeka · HRLeibniz Institute of Virology (LIV) · DESapienza University of Rome · ITUniversity of Alabama at Birmingham · US

Funding

Inflammation and Hearing Loss Following Congenital CMV InfectionR01DC015980 · NIDCD · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI BRITT, WILLIAM JARVIS, HIROSE, KEIKO · 2017 to 2021
$3.1M
NIDCD NIH HHS R01 DC015980
6 · The paper itself

Abstract

Congenital human cytomegalovirus (cHCMV) infection of the brain is associated with a wide range of neurocognitive sequelae. Using infection of newborn mice with mouse cytomegalovirus (MCMV) as a reliable model that recapitulates many aspects of cHCMV infection, including disseminated infection, CNS infection, altered neurodevelopment, and sensorineural hearing loss, we have previously shown that mitigation of inflammation prevented alterations in cerebellar development, suggesting that host inflammatory factors are key drivers of neurodevelopmental defects. Here, we show that MCMV infection causes a dramatic increase in the expression of the microglia-derived chemokines CXCL9/CXCL10, which recruit NK and ILC1 cells into the brain in a CXCR3-dependent manner. Surprisingly, brain-infiltrating innate immune cells not only were unable to control virus infection in the brain but also orchestrated pathological inflammatory responses, which lead to delays in cerebellar morphogenesis. Our results identify NK and ILC1 cells as the major mediators of immunopathology in response to virus infection in the developing CNS, which can be prevented by anti-IFN-γ antibodies.

Indexed as

AnimalsAnimals, NewbornBrainChemokine CXCL10Chemokine CXCL9CytomegalovirusCytomegalovirus InfectionsGene Expression RegulationHumansImmunity, InnateInflammationKiller Cells, NaturalLymphocytesMiceMice, 129 StrainMice, Inbred BALB CChemokine CXCL10Chemokine CXCL9Cxcr3 protein, mouseReceptors, CXCR3

Identifiers

PMID33630019
PMCPMC7918636
OpenAlexW3131888834

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.